Call Us + 33 1 84 88 31 00

Article R5141-21 of the French Public Health Code

When an application for authorisation concerns a generic veterinary medicinal product of a reference veterinary medicinal product which has not been authorised in France but which has been authorised in another Member State of the European Union, the applicant must indicate the Member State in which this reference veterinary medicinal product is or has been authorised. In this case, the Director General of the Agence nationale de sécurité sanitaire de…

Read More »

Article R5141-22 of the French Public Health Code

When informed by the holder of a marketing authorisation granted under 1°, 2° or 3° of Article R. 5141-20, before the marketing of the veterinary medicinal product concerned, of the fact that for all or part of the indications, pharmaceutical forms or strengths of the reference veterinary medicinal product the intellectual property rights have not expired, the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement…

Read More »

Article R5141-23 of the French Public Health Code

I. – For the application of 1° of article R. 5141-18 , when reference is made to published scientific literature, the experts shall justify the use of this bibliographical documentation and demonstrate that it meets the requirements of the protocols adopted pursuant to article R. 5141-2 , taking into account in particular the pharmaceutical form and the constituents of the excipient. II. – For the application of 5° of article…

Read More »

Article R5141-25 of the French Public Health Code

The experts referred to in Article L. 5141-16 shall have the following qualifications and experience, set out in a summary of the curriculum vitae attached to the marketing authorisation application dossier: 1° For the expert giving an opinion on the pharmaceutical documentation: as appropriate, a diploma allowing the practice of pharmacy or veterinary medicine, or a diploma in the field of chemistry, biology, microbiology or biotechnology and sufficient practical experience,…

Read More »

Article R5141-26 of the French Public Health Code

The marketing authorisation is granted by the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. It is accompanied by the summary of product characteristics referred to in Article R. 5141-15 as approved by the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. The authorisation indicates, where applicable, whether the medicinal product is covered by…

Read More »

Article R5141-27 of the French Public Health Code

During the examination of marketing authorisation applications, the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail may order any investigative measure he deems necessary and in particular: 1° Carry out any investigation relating to the manufacture of the medicinal product ; 2° Consult the experts who have been chosen to carry out the tests with a view to compiling the marketing authorisation…

Read More »

Article R5141-28 of the French Public Health Code

The Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail will make a decision within two hundred and ten days of the submission of a complete application. Silence on the part of the Director General will be deemed to constitute refusal of authorisation on expiry of a period of two hundred and ten days from submission of such a dossier. The Director General…

Read More »

Article R5141-29 of the French Public Health Code

The specific obligations that may be imposed in application of 1° of Article L. 5141-5-1 are as follows: 1° The applicant must complete a trial programme within a period set by the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, the results of which will be used to reassess the benefit/risk balance of the veterinary medicinal product; 2° The veterinary medicinal product in question must be…

Read More »

Article R5141-34 of the French Public Health Code

The marketing authorisation holder shall forward without delay to the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, including during the examination of the dossier, indicating its scope, any new data available to him or of which he is aware, in particular the results of studies or trials carried out inside or outside the European Union, which could lead to a change…

Read More »

Article R5141-34-1 of the French Public Health Code

At the request of the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, the marketing authorisation holder shall examine and, where appropriate, modify the analytical methods for detecting residues in the light of technical and scientific progress. He shall provide the substances necessary and in sufficient quantity to carry out the checks to detect the presence of residues of the veterinary medicinal…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.